Holostem and Chiesi Announce FDA Orphan Drug Designation for GPLSCD01 for treatment of Limbal Stem Cell Deficiency (LSCD)
Published on Nature the first life-saving epidermal stem cell-based gene therapy which has allowed international team coordinated by Prof. Michele De Luca of the University of Modena and Reggio Emilia to save the life of a child suffering from Epidermolysis Bullosa and achieve fundamental knowledge in the field of stem cell biology
